5JV0
Crystal structure of human FPPS in complex with an allosteric inhibitor CL-08-038
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-04-07 |
Detector | RIGAKU SATURN 944+ |
Wavelength(s) | 1.54178 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 111.540, 111.540, 75.980 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.700 - 2.400 |
R-factor | 0.17936 |
Rwork | 0.176 |
R-free | 0.23504 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 4qxs |
RMSD bond length | 0.022 |
RMSD bond angle | 2.132 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | REFMAC (5.8.0123) |
Refinement software | REFMAC (5.8.0123) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 41.700 | 2.460 |
High resolution limit [Å] | 2.400 | 2.400 |
Rmerge | 0.064 | 0.713 |
Number of reflections | 17150 | |
<I/σ(I)> | 31.9 | 2.1 |
Completeness [%] | 88.4 | 52.4 |
Redundancy | 12.1 | 5.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 295 | 0.85 M lithium sulfate, 0.425 M ammonium sulfate, 15% glycerol, 0.085 M tri-sodium citrate, pH 5.6 |